Stockscreener 앱 받기
0.8587
2.42%
-0.0213
시간 외 거래:
.87
0.0113
+1.32%
전일 마감가:
$0.88
열려 있는:
$0.88
하루 거래량:
469.49K
Relative Volume:
0.43
시가총액:
$71.77M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-0.5882
EPS:
-1.46
순현금흐름:
$-104.90M
1주 성능:
+11.27%
1개월 성능:
+11.88%
6개월 성능:
-66.46%
1년 성능:
-77.22%
1일 변동 폭
$0.8402
$0.9061
1주일 범위
$0.751
$0.9124
52주 변동 폭
$0.66
$3.93
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
CRBU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
0.8587 | 71.77M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Levi & Korsinsky Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Investors Can Still File Late Claims for Caribou Biosciences $3.9M Settlement Payouts - TradingView
Caribou Biosciences Inc [CRBU] Records 200-Day SMA of $1.6979 - knoxdaily.com
Taking the lead: Caribou Biosciences Inc (CRBU) - Sete News
Caribou Biosciences Investors Drop Suit Over Cell Therapy, Cash - Bloomberg Law News
Press Release Distribution & PR Platform - ACCESS Newswire
Is Caribou Biosciences Inc (CRBU) worth investing in despite its undervalued state? - uspostnews.com
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
Caribou Biosciences Inc (NASDAQ: CRBU) -0.30% Decline Turns Investors Away - Stocksregister
Geode Capital Management LLC Sells 58,048 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
H.C. Wainwright cuts Caribou Biosciences stock target to $3 By Investing.com - Investing.com India
H.C. Wainwright cuts Caribou Biosciences stock target to $3 - Investing.com Australia
Caribou Biosciences (CRBU) Target Price Cut Amid Strategic Shift - GuruFocus
Quarterly Snapshot: Quick and Current Ratios for Caribou Biosciences Inc (CRBU) - DWinneX
Caribou Biosciences Inc (CRBU) Stock: A Year of Decreases and Increases - investchronicle.com
Caribou Biosciences Inc (CRBU) receives an In-line rating from Evercore ISI - knoxdaily.com
Caribou Biosciences (CRBU) Target Price Cut Amid Strategic Shift | CRBU Stock News - GuruFocus
Caribou Biosciences (CRBU) Sees Price Target Cut Amid Strategic - GuruFocus
Russell Investments Group Ltd. Boosts Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies - MedCity News
Caribou Biosciences (CRBU) Restructures, Focuses on Key Oncology Programs - GuruFocus
Caribou stock in focus after portfolio shakeup (CRBU:NASDAQ) - Seeking Alpha
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff - Yahoo Finance
Caribou Biosciences rises on job cuts, shifts focus to cancer therapies - TradingView
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs - marketscreener.com
Caribou Biosciences (CRBU) Shifts Focus to Oncology, Reduces Wor - GuruFocus
Caribou Biosciences Inc [CRBU] Shares Fall Approximately -78.12% Over the Year - knoxdaily.com
Caribou Biosciences extends cash runway, focuses on oncology - Investing.com India
Caribou Biosciences, Inc. Announces Strategic Pipeline Prioritization and Workforce Reductions to Extend Cash Runway into H2 2027 - Nasdaq
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 ... - Enidnews.com
East Bay biotech to cut a third of its workforce, reset around two cancer programs - The Business Journals
Caribou Biosciences Inc (CRBU) stock analysis: A simple moving average approach - uspostnews.com
CRBU’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Recent Insider Activity Suggests Potential Gains for Caribou Biosciences Inc (CRBU) - knoxdaily.com
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by JPMorgan Chase & Co. - Defense World
Brokerages Set Caribou Biosciences, Inc. (NASDAQ:CRBU) PT at $10.33 - Defense World
Q1 Earnings Estimate for CRBU Issued By Leerink Partnrs - Defense World
THE ROSEN LAW FIRM, P. A., Caribou Biosciences, Inc. - The Bradford Era
Investigation announced for Long-Term Investors in shares - openPR.com
American Century Companies Inc. Grows Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Sei Investments Co. Buys New Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Prudential Financial Inc. Sells 111,100 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect - markets.businessinsider.com
Caribou Biosciences Inc [CRBU] President and CEO makes an insider purchase of 20,000 shares worth 20400.0. - knoxdaily.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Thrivent Financial for Lutherans Acquires 79,636 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences stock hits 52-week low at $0.71 - Investing.com India
Caribou Biosciences stock hits 52-week low at $0.71 By Investing.com - Investing.com South Africa
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):